In the US, opioid-maker Purdue is bankrupt. Its global counterparts make millions.
In the US, opioid-maker Purdue is bankrupt. Its global counterparts make millions.
Tactics used to persuade U.S. doctors that potent painkillers could be safely prescribed have been used abroad, an investigation shows.
In the United States, Purdue Pharma, the drugmaker accused of fueling the opioid crisis through its aggressive marketing of highly addictive pain pills, is bankrupt and facing thousands of lawsuits.
Globally, its counterparts are selling opioids — and still profiting.
Among the beneficiaries: some members of the Sackler family, who own Purdue and also sit atop a group of international companies known as Mundipharma, records show. The family faces a wave of litigation over Purdue’s alleged role in an opioid crisis that has claimed hundreds of thousands of lives and ruined countless more across the United States. (The Examination and The Washington Post, USA, 17.09.2024)
https://www.theexamination.org/articles/in-the-us-opioid-maker-purdue-is-bankrupt-its-global-counterparts-make-millions